IBG in three months: buy, wait or sell?
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
- Buy / Wait / Sell rating
- 3-month target price
- Bear · Base · Bull
- vs. the market
What happened with IBG today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Innovation Beverage Group Limited develops and manufactures beverage brands, but Australian Bitters Company accounts for nearly all its revenue. It produces the bitters at its Seven Hills facility in Australia and sells most of them to Coca-Cola Europacific Partners (CCEP) under a long-term contract. The company has exclusive manufacturing rights in Australia, while CCEP holds the Australian distribution rights. This makes CCEP both its main customer and the partner on which its principal route to market depends.
The company also exports bitters and sells beverages directly to consumers through Bevmart.com.au, which carries its own products and other brands. These activities contribute much less revenue than its Australian bitters business. In the United States, it must sell to retail outlets through state-licensed distributors or state-owned agencies, rather than supplying retailers freely.
The company has acquired a controlling interest in BlockFuel Energy and provided it with a loan in connection with a proposed merger. If completed, the merger would shift the business toward acquiring, developing and operating oil and gas assets integrated with digital energy infrastructure. Completion remains subject to conditions, including Nasdaq approval; that shift is a plan, not the current beverage revenue model.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
IBG’s results hinge on CCEP’s Australian bitters orders and competition with Angostura Bitters, rather than broad beverage-sector trends.
Coca-Cola Europacific Partners (CCEP), which makes beverages and sells them to customers and vending partners, buys most of IBG’s Australian bitters under a contract expiring in 2033, making its orders crucial to IBG’s revenue. Watch its Australian bitters order timing: a missed CCEP order cycle left IBG with 11 months of recognized sales in 2025 versus 12 in 2024 and was the main reason revenue fell.
No upcoming items to show.
Earnings, filings and other dated events show up here once their dates are set.